Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of talnetant vs.
risperidone vs. placebo in reducing positive and negative symptoms in acutely psychotic
schizophrenia patients.